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Cockayne syndrome (CS) is a photosensitive, DNA repair disorder associated with progeria that is caused by a defect in
the transcription-coupled repair subpathway of nucleotide excision repair (NER). Here, complete inactivation of NER in
Csb
m/m/Xpa
 /  mutants causes a phenotype that reliably mimics the human progeroid CS syndrome. Newborn Csb
m/m/
Xpa
 / mice display attenuated growth, progressive neurological dysfunction, retinal degeneration, cachexia, kyphosis,
and die before weaning. Mouse liver transcriptome analysis and several physiological endpoints revealed systemic
suppression of the growth hormone/insulin-like growth factor 1 (GH/IGF1) somatotroph axis and oxidative
metabolism, increased antioxidant responses, and hypoglycemia together with hepatic glycogen and fat accumulation.
Broad genome-wide parallels between Csb
m/m/Xpa
 /  and naturally aged mouse liver transcriptomes suggested that
these changes are intrinsic to natural ageing and the DNA repair–deficient mice. Importantly, wild-type mice exposed
to a low dose of chronic genotoxic stress recapitulated this response, thereby pointing to a novel link between genome
instability and the age-related decline of the somatotroph axis.
Citation: van der Pluijm I, Garinis GA, Brandt RMC, Gorgels TGMF, Wijnhoven SW, et al. (2007) Impaired genome maintenance suppresses the growth hormone–insulin-like
growth factor 1 axis in mice with Cockayne syndrome. PLoS Biol 5(1): e2. doi:10.1371/journal.pbio.0050002
Introduction
A prevailing hypothesis to explain the molecular basis of
ageing is Harman’s ‘‘free-radical theory of ageing’’, which
states that endogenous reactive oxygen species (ROS), which
result from cellular metabolism, continually damage biomo-
lecules [1]. In line with this hypothesis, it has been shown that
increased resistance to oxidative stress (e.g., by improved
antioxidant defense) extends the lifespan of Caenorhabditis
elegans, Drosophila, and rodents [2–4], whereas hypersensitivity
to oxygen considerably reduces the lifespan of nematodes [5].
A key macromolecule at risk for ROS-mediated damage is
nuclear DNA [1], which is evident from the wide range of
oxidative DNA lesions that accumulate gradually in rodents
and humans with advancing age [6,7].
In humans, the causative role of DNA damage in ageing is
supported by a variety of progeroid disorders with defects in
DNA repair pathways [8,9]. One such condition is Cockayne
syndrome (CS) (affected genes: CSA or CSB), a photosensitive
disorder that originates from a defect in transcription-
coupled repair (TCR), which speciﬁcally removes DNA lesions
that obstruct RNA polymerases, allowing resumption of
transcription and promoting cellular survival from DNA
damage. TCR of helix-distorting DNA damage is a dedicated
subpathway of the multi-step ‘‘cut-and-patch’’ nucleotide
excision repair (NER) system, and is designated TC-NER [10]
to distinguish it from the so-called global genome NER (GG-
NER) subpathway that operates genome-wide to eliminate
distorting damage. Available evidence suggests that CS cells
are also defective in TCR of non–helix distorting DNA lesions
that block transcription such as transcription-blocking
oxidative DNA lesions [11,12], which are normally genome-
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PLoS BIOLOGYwide removed by base excision repair. We will use the term
TCR when referring to transcription-coupled repair in
general.
CS patients present with growth failure (cachectic dwarf-
ism), progressive neurological abnormalities (including de-
layed psychomotor development, mental retardation,
microcephaly, gait ataxia, sensorineural hearing loss, retinal
degeneration), along with impaired sexual development,
kyphosis, osteoporosis, and severely reduced lifespan (mean
age of death: 12.5 y) [13,14]. A related yet distinct disorder is
trichothiodystrophy (TTD) (affected genes: XPB, XPD, or
TTDA). TTD patients are partially defective in TCR as well as
in the GG-NER, and share the symptoms associated with CS.
In addition, these patients have a partial defect in tran-
scription itself, causing additional symptoms such as ichthyo-
sis and brittle hair and nails [15]. Many of the CS and TTD
features are progressive and resemble premature ageing.
Because patients develop some but not all aspects of normal
ageing in an accelerated manner, CS and TTD are considered
‘‘segmental progeroid syndromes’’ [8].
Mouse mutants for CS-A and CS-B reliably mimic the UV
sensitivity of CS patients and show accelerated photoreceptor
loss, reduced body weight, and mild neurologic abnormalities
[16,17]. Similarly, mice homozygous for a causative TTD point
mutation in the Xpd gene faithfully mirror the symptoms in
TTD patients [9], whereas complete inactivation of NER (by
concurrent inactivation of the Xpa gene) dramatically
aggravates the CS features of partially NER-defective TTD
mice [9]. These observations, together with the notion that
DNA lesions can provoke a permanent cell cycle arrest or
apoptosis, led us to propose that ageing can result from
(oxidative) DNA lesions that interfere with transcription and/
or replication causing cell death or cellular senescence,
ultimately leading to the loss of tissue homeostasis and the
onset of age-related diseases [18–20].
Here we report that mice with engineered mutations in
both Csb and Xpa genes display many CS features in a
dramatic form, including postnatal growth attenuation,
progressive kyphosis, ataxia, retinal degeneration, motor
dysfunction, and premature death. Importantly, full genome
transcriptome analysis of the Csb
m/m/Xpa
 /  mouse liver at the
age of 15 d uncovered a systemic response seen also in wild-
type (wt) mice exposed to chronic oxidative stress. These
ﬁndings disclose a novel link between DNA damage,
compromised genome maintenance, and the somatotrophic
axis that determines lifespan and shed new light on the
etiology of Cockayne syndrome and natural ageing.
Results
Attenuated Growth and Perinatal Death in Csb
m/m/Xpa
 / 
and Csb
m/m/Xpc
 /  Mice
TCR-defective Csb
m/m mutant mice [16] were intercrossed
with GG-NER-defective Xpc
 /  [21] and GG/TC-NER-defective
Xpa
 /  [22] animals to investigate whether an increase in the
endogenous burden of unrepaired DNA damage, as provoked
by the inactivation of GG-NER, enhances the phenotype,
including progeroid features. Analysis of UV-induced repair
synthesis and RNA synthesis recovery (indicative for GG-NER
and TC-NER capacity, respectively) conﬁrmed complete
inactivation of NER in Csb
m/m/Xpa
 /  and Csb
m/m/Xpc
 /  animals
(Figure 1A). As expected on the basis of previous work, Xpa
 / 
cells display the highest UV sensitivity, whereas Xpc
 /  and
Csb
m/m cells show intermediate sensitivities (Xpa
 /  . Csb
m/m .
Xpc
 /  . wt; see Figure 1B). Interestingly, inactivation of GG-
NER in Csb
m/m mouse embryonic ﬁbroblasts (MEFs) (as in
Csb
m/m/Xpa
 /  and Csb
m/m/Xpc
 /  cells) renders cells more UV-
sensitive than already completely NER-deﬁcient Xpa
 /  MEFs.
We attribute this enhanced sensitivity to the absence of CSB-
mediated TCR of UV-induced lesions that do not form a
substrate for NER. Thus, the repair defect in the double
mutant appears to be more severe than that of the single
mutants. We could not detect a similar increased sensitivity to
ionizing radiation in double-mutant cells above that of Csb
m/m
cells [12] (unpublished data), supporting the notion that MEFs
in culture are already under high oxygen stress [23,24].
As evident from their overall appearance and weight
(Figure 1C–1E), Csb
m/m/Xpa
 /  and Csb
m/m/Xpc
 /  pups (hybrid
C57BL/6Jx129ola genetic background) displayed a strikingly
attenuated growth, resulting in pronounced dwarﬁsm.
Whereas the number of double mutant pups was ;3-fold
below that expected for Mendelian inheritance (Table S1),
embryonic day 18/5 (E18.5) Csb
m/m/Xpa
 /  and Csb
m/m/Xpc
 / 
embryos were present at Mendelian frequency, pointing to
considerable lethality during or shortly after birth. Impor-
tantly, double-mutant embryos were morphologically and
histologically indistinguishable from wt and single-mutant
embryos (Figure 1F and unpublished data), indicating that the
growth defect was postnatal and did not reﬂect impaired
embryonic development per se. In the third week of life,
however, Csb
m/m/Xpa
 /  and Csb
m/m/Xpc
 /  pups developed
progressive cachexia (evident from the weight loss after day
15; see Figure 1E), ultimately resulting in death before
postnatal day 22. Neither moistening of food pellets (to
facilitate intake of solids) nor removal of wt or single-mutant
pups from the litter (to reduce competition for breast milk)
improved the physical condition or the lifespan of Csb
m/m/
Xpa
 /  and Csb
m/m/Xpc
 /  pups. Necropsy revealed milk or solid
food in the stomach, indicating that insufﬁcient access to
supplied nutrition was not the underlying cause of growth
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Author Summary
Normal metabolism routinely produces reactive oxygen species that
damage DNA and other cellular components and is thought to
contribute to the ageing process. Although DNA damage is typically
kept in check by a variety of enzymes, several premature ageing
disorders result from failure to remove damage from active genes.
Patients with Cockayne syndrome (CS), a genetic mutation affecting
one class of DNA repair enzymes, display severe growth retardation,
neurological symptoms, and signs of premature ageing followed by
an early death. Whereas mouse models for CS exhibit relatively mild
deficits, we show that concomitant inactivation of a second DNA
repair gene elicits severe CS pathology and ageing. Moreover, a few
days after birth, these mice undergo systemic suppression of genes
controlling growth, an unexpected decrease in oxidative metabo-
lism, and an increased antioxidant response. Similar physiological
changes are also triggered in normal mice by chronic exposure to
DNA-damaging oxidative stress. From these findings, we conclude
that DNA damage triggers a response aimed at limiting oxidative
DNA damage levels (and associated tissue degeneration) to extend
lifespan and promote healthy ageing. Better understanding of the
ageing process will help to delineate intervention strategies to
combat age-associated pathology.retardation, weight loss, and early death. Importantly,
progressive growth retardation, cachexia, and short life
expectation (;12.5 y) are also observed in human patients
with CS [13]. Combined inactivation of Xpa and Xpc rendered
mice without any overt phenotype (unpublished data),
leading us to conclude that the dramatic phenotype of
Csb
m/m/Xpa
 /  and Csb
m/m/Xpc
 /  pups results from a combined
GG-NER/TC-NER/TCR defect.
Growth and Neurological Abnormalities in Csb
m/m/Xpa
 / 
Mice
Further analysis of the Csb
m/m/Xpa
 /  phenotype, performed
in an isogenic C57BL/6J background, revealed a near-normal
size of the skull at day 11 and 21 (autoradiographs shown in
Figure 2A), implying that the (postnatal) growth defect is
restricted to the trunk, and to a lesser extent, the extremities.
All 21-d-old double-mutant animals showed kyphosis (abnor-
mal curvature of the spinal column, Figure 2A, middle left
and bottom right), which was also observed in younger Csb
m/m/
Xpa
 /  pups, indicating that it is not determined by terminal
illness. The normal appearance of the spine in 11-d-old
double-mutant pups excluded a prenatal developmental
defect and further pointed to an extremely accelerated onset
of kyphosis, a feature observed in naturally aged (2-y old)
C57BL/6J mice (see Figure 2A, bottom left panel). Two-
dimensional images of proximal end-to-mid-diaphysis micro–
computed tomography (micro-CT) scans of ﬁxed tibiae from
10-, 15-, and 20-d-old wt and Csb
m/m/Xpa
 /  mice revealed
Figure 1. Growth Retardation, Cachexia, and Premature Death in Csb
m/m/Xpa
 /  and Csb
m/m/Xpc
 /  Mice
(A) UV repair characteristics of wt, single-mutant, and double-mutant primary MEFs. UV-induced UDS (left panel) and recovery of RNA Synthesis (RRS,
right panel) are indicative for GG-NER and TC-NER capacity, respectively. For a detailed explanation of the procedure, see Methods. Error bars indicate
standard error of the mean (SEM).
(B) Survival of primary MEFs exposed to increasing doses of UV-C light (254 nm), as determined using the with [
3H]-thymidine incorporation assay. Error
bars (in most cases smaller than symbols used) indicate SEM.
(C) Photograph of a 14-d-old Csb
m/m/Xpa
 /  mouse with an Xpa
 /  littermate (hybrid 129Ola/C57BL/6J background).
(D) Photograph of an 8-d-old Csb
m/m/Xpc
 /  mouse with a Csb
m/m littermate (hybrid 129Ola/C57BL/6J background).
(E) Body weight curve of Csb
m/m/Xpa
 / and Csb
m/m/Xpc
 / mice (n¼7) compared to those defective in a single NER gene (n¼7) all in a hybrid 129Ola/
C57BL/6J background. The arrow indicates birth. Error bars (in most cases smaller than symbols used) indicate SEM.
(F) Photographs of day 18.5 Csb
m/m/Xpa
 /  and Xpa
 /  embryos (C57BL/6J).
doi:10.1371/journal.pbio.0050002.g001
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m/m/Xpa
 /  Miceretarded, yet steady, longitudinal as well as radial (perimeter)
growth, along with a thinner bone cortex and a less developed
growth plate (Figure 2B). In line with this observation, we
observed a reduction in tibia length (Figure 2C). Notably,
whereas Csb
m/m/Xpa
 /  pups lose weight in the third week of
life, bone growth proceeds, resulting in relatively large
extremities, a representative feature of CS and TTD [13].
Motor coordination problems, manifesting as tremors and
abnormal posture of the hind limbs (ﬂexion rather than
extension in tail suspension test), became evident around day
10 in Csb
m/m/Xpa
 /  mice (unpublished data). Foot print
analysis revealed a disturbed gait from day 15 onwards.
Whereas wt and single-mutant animals maintained a straight
path with regular alternating strides, Csb
m/m/Xpa
 /  mice
demonstrated a nonuniform alternating left-right step
pattern and unevenly spaced shorter strides (Figure 2D).
Despite their runted size, the front base width of Csb
m/m/Xpa
 / 
animals was signiﬁcantly greater than that of wt and single-
mutant littermates, which likely illustrates an attempt to
maintain balance (Figure 2D). These data are consistent with
Figure 2. Skeletal and Neurological Abnormalities in Csb
m/m/Xpa
 /  Mice
(A) Radiographs of wt and Csb
m/m/Xpa
 /  mice (age as indicated) and photograph of a 15-d-old Csb
m/m/Xpa
 /  mouse (C57BL/6J).
(B) 2-D images of micro-CT scans of tibiae taken from Csb
m/m/Xpa
 / animals and wt littermate controls (age indicated in the figure). Horizontal sections
are shown of the upper and lower part of the tibiae. e, epiphysis; g, growth plate; and d, diaphysis. I indicates the section through the smaller part of the
diaphysis, II indicates section through the broader part of the diaphysis.
(C) Growth of tibiae, taken from Csb
m/m/Xpa
 /  animals (light squares) and wt littermate controls (dark squares).
(D) Representative footprint patterns of 19-d-old wt and Csb
m/m/Xpa
 / mice. Arrows indicate the trajectory of each mouse. Stride length and front base
width measurements on 15-d-old wt, Xpa
 / , Csb
m/m, and Csb
m/m/Xpa
 /  mice. The significantly (asterisk; p , 0.001) greater base width in the double
mutant mouse indicates ataxia.
(E) Representative pictures of a TUNEL staining in the retina of wt and Csb
m/m/Xpa
 /  mice and quantification of the number of TUNEL positive cells.
Arrows indicate TUNEL positive cells in the ONL and INL. Note the significantly higher number of TUNEL-positive cells in both the ONL and the INL in the
retina of Csb
m/m/Xpa
 /  compared to wt mice (asterisk; p , 0.05).
doi:10.1371/journal.pbio.0050002.g002
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m/m/Xpa
 /  Micethe profound early postnatal ataxia and abnormal cerebellar
development in Csb
m/m/Xpa
 /  mice [25] and the progressive
neurodegeneration observed in human CS patients [26].
We next examined the retinas of 15-d-old Csb
m/m/Xpa
 / 
pups for the presence of apoptotic cells, because retinal
degeneration is a prominent neurological feature of CS
patients [27] and adult CS mice (T. Gorgels, I. van der Pluijm,
R. Brandt, G. Garinis, H. van Steeg, et al., unpublished data).
At this age, cell loss occurs as part of the normal development
of the retina. Yet, as shown by terminal deoxynucleotidyl-
transferase-mediated dUTP nick end labeling (TUNEL)
(Figure 2E) and caspase-3 staining (unpublished data), the
number of apoptotic cells in the outer nuclear layer (ONL)
and inner nuclear layer (INL) of the retinas of Csb
m/m/Xpa
 / 
pups was signiﬁcantly increased (analysis of variance [AN-
OVA], S-N-K posthoc test, p , 0.05), as compared to wt and
single-mutant littermates (Figure 2E). Thus, the Xpa defect
enhanced the apoptotic sensitivity of photoreceptor cells in
Csb
m/m mice, thereby pointing to DNA damage as a trigger for
age-related retinal degeneration. Because 15-d-old Csb
m/m
Figure 3. Histological Examination of Csb
m/m/Xpa
 /  Tissues
(A) BrdU staining of the jejunum of Csb
m/m/Xpa
 /  and littermate control
mice, showing normal proliferative capacity of the intestine in the
double mutant mouse. (B–E) Histological examination of liver sections of
15-d-old Csb
m/m/Xpa
 /  and littermate control mice, stained with HE (B),
immunostained for the proliferation markers (incorporated) BrdU (C) and
PCNA protein (D), or TUNEL-stained for the presence of apoptotic cells
(E). Quantification of the number of proliferative or apoptotic cells did
not reveal significant differences between Csb
m/m/Xpa
 /  and wt
littermate mice. (F) HE staining of the pituitary of Csb
m/m/Xpa
 /  and
littermate control mice.
doi:10.1371/journal.pbio.0050002.g003
Figure 4. Enhanced Sensitivity of Csb
m/m/Xpa
 /  Retinal Photoreceptor
Cells to Genotoxic Insults
Representative pictures of TUNEL stained retinas of 19-d-old wt, Csb
m/m,
Xpa
 / , and Csb
m/m/Xpa
 /  mice (right panel), 20 h after exposure of
animals to 10 Gy of ionizing radiation, and quantification of the number
of TUNEL positive cells in the ONL (left panel). Note the significantly
higher number of TUNEL-positive cells in the retina of Csb
m/m/Xpa
 / 
mice, as compared to wt and single-mutant littermate controls (p ,
0.05). Single asterisks indicate statistically significant differences between
unirradiated Csb
m/m/Xpa
 /  and littermate control mice (p , 0.05),
double asterisks indicate statistically significant differences between
unirradiated and irradiated Csb
m/m/Xpa
 /  mice (p , 0.05).
doi:10.1371/journal.pbio.0050002.g004
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m/m/Xpa
 /  MiceTable 1. Significant Gene Expression Changes in the Livers of Csb
m/mXpa
 / , Csb
m/m, and Xpa
 /  Mice Compared to Livers from
Littermate Controls
Process Code Title Symbol Csb
m/mXpa
 /  Xpa
 /  Csb
m/m
FC p-
value
FC p-
value
FC p-
value
The IGF-1/GH growth axis 1448556_at prolactin receptor Prlr  2.03 0.000  1.25 0.10  1.10 0.66
1419519_at insulin-like growth factor 1 Igf1  2.13 0.000  1.08 0.16  1.13 0.19
1421991_a_at IGF-binding protein 4 Igfbp4  1.74 0.000  1.07 0.82  1.16 0.39
1458268_s_at IGF-binding protein 3 Igfbp3  1.44 0.001  1.10 0.25 1.06 0.59
1422826_at IGF binding protein, acid labile subunit Igfals  2.36 0.000 1.06 0.53 1.13 0.26
1417962_s_at growth hormone receptor Ghr  1.53 0.000 1.03 0.15 1.10 0.05
1425458_a_at growth factor receptor bound protein 10 Grb10 1.84 0.000 1.11 0.59 1.24 0.19
1427777_x_at fibroblast growth factor receptor 4 Fgfr4  1.32 0.009  1.12 0.71  1.19 0.11
1421841_at fibroblast growth factor receptor 3 Fgfr3  1.43 0.001  1.32 0.03  1.12 0.87
1450869_at fibroblast growth factor 1 Fgf1  1.38 0.003  1.20 0.09  1.01 0.84
1435663_at estrogen receptor 1 (alpha) Esr1  1.91 0.001  1.12 0.32  1.31 0.12
1417991_at deiodinase, iodothyronine, type I Dio1  2.12 0.000 1.00 0.28  1.04 0.28
Carbohydrate metabolism 1423644_at aconitase 1 Aco1  1.26 0.002 1.05 0.50  1.00 0.96
1422577_at citrate synthase Cs  1.28 0.006 1.16 0.20  1.03 0.20
1419146_a_at glucokinase Gck  6.59 0.004 1.16 0.28  1.01 0.66
1424815_at glycogen synthase 2 Gys2 1.78 0.000  1.03 0.22  1.01 0.30
1459522_s_at glycogenin 1 Gyg1 1.26 0.014 1.05 0.15 1.03 0.36
1417741_at liver glycogen phosphorylase Pygl  1.42 0.000 1.02 0.50 1.06 0.03
Steroid metabolism and
biosynthesis
1417871_at hydroxysteroid (17-beta) dehydrogenase 7 Hsd17b7  1.50 0.000  1.33 0.14  1.32 0.13
1449038_at hydroxysteroid 11-beta dehydrogenase 1 Hsd11b1  1.32 0.001 1.10 0.34 1.01 0.71
1460192_at oxysterol binding protein-like 1A Osbpl1a  1.38 0.000  1.10 0.50  1.08 0.52
1427345_a_at sulfotransferase family 1A, member 1 Sult1a1  1.29 0.002  1.05 0.69  1.05 0.59
1419528_at sulfotransferase, hydroxysteroid
preferring 2
Sth2  1.61 0.000  1.08 0.92  1.20 0.26
Cytochrome (Cyt) P450, NADH-
and NADPH- dependent
oxidative metabolism
1418821_at Cyt. P450, family 2, subfam. a, polyp. 12 Cyp2a12  1.51 0.000 1.06 0.21  1.06 0.33
1422257_s_at Cyt. P450, family 2, subfam. b, polyp. 10 Cyp2b10  2.81 0.001  1.40 0.75  1.39 0.75
1449479_at Cyt. P450, family 2, subfam. b, polyp. 13 Cyp2b13  2.24 0.002  1.19 0.77  1.27 0.98
1425645_s_at Cyt. P450, family 2, subfam. b, polyp. 20 Cyp2b20  2.94 0.001  1.29 0.95  1.42 0.36
1419590_at Cyt. P450, family 2, subfam. b, polyp. 9 Cyp2b9  1.55 0.000  1.06 0.78  1.04 0.49
1417651_at Cyt. P450, family 2, subfam. c, polyp. 29 Cyp2c29  1.59 0.004  1.37 0.09  1.41 0.09
1440327_at Cyt. P450, family 2, subfam. c, polyp. 70 Cyp2c70  2.58 0.001  1.17 0.15  1.23 0.58
1448792_a_at Cyt. P450, family 2, subfam. f, polyp. 2 Cyp2f2  2.36 0.001 1.76 0.05 1.30 0.43
1417532_at Cyt. P450, family 2, subfam. j, polyp. 5 Cyp2j5  3.08 0.000  1.47 0.10  1.31 0.36
1418767_at Cyt. P450, family 4, subfam. f, polyp. 13 Cyp4f13  1.67 0.008  1.11 0.46  1.40 0.36
1419559_at Cyt. P450, family 4, subfam. f, polyp. 14 Cyp4f14  3.58 0.000 1.57 0.06  1.00 0.92
1417070_at Cyt. P450, family 4, subfam. v, polyp. 3 Cyp4v3  1.41 0.001 1.04 0.40  1.09 0.81
1422100_at Cyt. P450, family 7, subfam. a, polyp. 1 Cyp7a1  2.36 0.006 1.14 0.86  1.39 0.24
1417429_at flavin containing monooxygenase 1 Fmo1  1.38 0.000 1.04 0.23 1.00 0.57
1422904_at flavin containing monooxygenase 2 Fmo2  4.51 0.008  2.17 0.40  2.05 0.49
1449525_at flavin containing monooxygenase 3 Fmo3  14.19 0.004  2.03 0.84  2.34 0.59
1423908_at NADH dehydrogenase (ubiquinone)
Fe-S protein 8
Ndufs8  1.23 0.002 1.02 0.87  1.04 0.13
Antioxidant and
detoxification response
1422438_at epoxide hydrolase 1, microsomal Ephx1 2.10 0.000 1.14 0.30  1.12 0.02
1421816_at glutathione reductase 1 Gsr 1.20 0.009 1.19 0.18  1.01 0.95
1421041_s_at glutathione S-transferase, alpha 2 (Yc2) Gsta2 1.90 0.003  1.18 0.09  1.59 0.51
1416842_at glutathione S-transferase, mu 5 Gstm5 1.29 0.000 1.02 0.82  1.02 0.34
1449575_a_at glutathione S-transferase, pi 2 Gstp2 1.40 0.000 1.07 0.64 1.07 0.69
1417883_at glutathione S-transferase, theta 2 Gstt2 2.76 0.000 1.18 0.13  1.30 0.05
1448239_at heme oxygenase (decycling) 1 Hmox1 2.43 0.000  1.48 0.04  1.17 0.12
1452592_at microsomal glutathione S-transferase 2 Mgst2 2.89 0.000 1.02 0.29 1.10 0.29
1448300_at microsomal glutathione S-transferase 3 Mgst3 1.49 0.001 1.29 0.04 1.02 0.10
1430979_a_at peroxiredoxin 2 Prdx2 1.61 0.001 1.75 0.01 1.34 0.26
1416292_at peroxiredoxin 3 Prdx3 1.27 0.010 1.24 0.19 1.09 0.18
1451124_at superoxide dismutase 1, soluble Sod1 1.22 0.003 1.26 0.03 1.16 0.10
1415996_at thioredoxin interacting protein Txnip 2.11 0.008 1.05 0.49 1.05 0.42
1440221_at thioredoxin-like Txnl 1.50 0.002 1.26 0.58 1.17 0.83
Peroxisomal biogenesis 1416679_at ATP-binding cassette, sub-family
D member 3
Abcd3  1.29 0.000 1.03 0.63 1.03 0.60
1449442_at peroxisomal biogenesis factor 11a Pex11a  1.78 0.010  1.97 0.04  1.60 0.37
1451213_at peroxisomal biogenesis factor 11b Pex11b  1.24 0.010  1.03 0.82  1.05 0.69
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m/m/Xpa
 /  Micemice still have wt levels of apoptotic cells, spontaneous
photoreceptor loss in the Csb
m/m mouse initiates in the second/
third month of life.
Visual inspection and histological analysis of most internal
organs of 15-d-old Csb
m/m/Xpa
 /  mice did not reveal any
obvious pathological abnormalities (unpublished data), with
the exception of substantial loss of abdominal fat. Because we
did not ﬁnd any sign of infections, necrosis, or abnormal
cellular proliferation (as determined by bromodeoxyuridine
[BrdU] staining) in the gastrointestinal tract of 15- and 21-d-
old Csb
m/m/Xpa
 /  animals, intestinal malfunction is an
unlikely cause of the growth defect (Figure 3A). In addition,
the liver had a normal histological appearance (Figure 3B),
whereas neither BrdU (Figure 3C), proliferating cell nuclear
antigen (PCNA) (Figure 3D), and Ki67 staining (unpublished
data), nor TUNEL (Figure 3E) and caspase-3 staining
(unpublished data) revealed any signiﬁcant difference be-
tween Csb
m/m/Xpa
 /  and wt livers. This ﬁnding indicates that
aberrant cell proliferation or apoptosis in the liver does not
likely contribute to the Csb
m/m/Xpa
 /  phenotype. Moreover,
inactivation of the p53 tumor-suppressor gene failed to
rescue the mutant phenotype, because Csb
m/m/Xpa
 / /p53
 / 
triple-mutant pups appeared indistinguishable from Csb
m/m/
Xpa
 /  pups (unpublished data). Thus, the precise etiology of
the overall physical deterioration and the cause of death of
Csb
m/m/Xpa
 /  mice remain unknown.
Enhanced Ionizing Radiation Sensitivity of the Csb
m/m/
Xpa
 /  Mouse Retina
The spontaneous, age-related and ionizing radiation (IR)–
induced loss of post-mitotic photoreceptor cells in Csb
m/m
mice underscores the relevance of DNA repair in the removal
of (oxidative) DNA damage for the long-term survival of
terminally differentiated cells in the retina (T. Gorgels, I. van
der Pluijm, R. Brandt, G. Garinis, H. van Steeg, et al.,
unpublished data). To test whether Csb
m/m/Xpa
 /  animals are
more sensitive to genotoxic insults than are single-mutant
Csb
m/m and Xpa
 /  animals, we next examined if the additional
Xpa defect further enhances the IR sensitivity of the Csb
m/m
retina. To this end, we exposed 18-d-old Csb
m/m/Xpa
 /  pups
and wt and single-mutant littermates to c rays (10 Gy) and
quantiﬁed the number of apoptotic cells in the retina by
TUNEL staining 20 h after exposure. As shown in Figure 4,
the number of apoptotic cells in the ONL of untreated (19-d-
old) Csb
m/m/Xpa
 /  pups further increased, as compared to 15-
d-old double-mutant animals (see Figure 2E). Whereas IR
exposure did not increase the frequency of apoptotic
photoreceptors in the ONL of wt and Xpa
 /  animals, Csb
m/m
mice already show a tendency to increased photoreceptor
loss, as characteristic for mature Csb
m/m animals (T. Gorgels, I.
van der Pluijm, R. Brandt, G. Garinis, H. van Steeg, et al.,
unpublished data). In contrast, the retinas of IR-exposed
Csb
m/m/Xpa
 /  animals showed an almost 2-fold increase in the
level of TUNEL-positive photoreceptor cells (Student’s t-test;
p ¼ 0.021). Taken together, these ﬁndings not only further
point to unrepaired DNA damage (likely originating from
oxidative stress) as the underlying trigger for photoreceptor
loss, but importantly, also show that inactivation of Xpa
further enhances the sensitivity of Csb
m/m mice to genotoxic
stress.
Analysis of the Csb
m/m/Xpa
 /  Mouse Liver Transcriptome
To investigate whether a disturbance in growth and
metabolism could explain the pronounced accelerated
organismal deterioration seen in Csb
m/m/Xpa
 /  mice, we
evaluated the liver transcriptome of 15-d-old wt, single-
mutant, and double-mutant mice (n¼4 mice). At this age, the
Csb
m/m/Xpa
 /  pups have not yet become cachectic. Two-tailed
t test analysis Affymetrix full mouse genome arrays revealed
1,865 genes with signiﬁcantly changed expression patterns
between wt and Csb
m/m/Xpa
 /  livers (p   0.01, 1.2-fold change
up- or down-regulated, Table S2), a number that signiﬁcantly
exceeds the ;80 genes that are expected to occur by chance
under these selection criteria. Among the set of 1,865 genes,
we identiﬁed those gene ontology (GO)–classiﬁed biological
processes with a signiﬁcantly disproportionate number of
responsive genes relative to those printed on microarrays
(false detection rate   0.10). This unbiased approach revealed
Table 1. Continued.
Process Code Title Symbol Csb
m/mXpa
 /  Xpa
 /  Csb
m/m
FC p-
value
FC p-
value
FC p-
value
Fatty acid biosynthesis
and elongation
1455994_x_at ELOVL1 long chain fatty acid elongatiion Elovl1 1.28 0.001 1.24 0.03 1.22 0.08
1417403_at ELOVL6, long chain fatty acid elongatiion Elovl6 1.37 0.001 1.18 0.23 1.09 0.38
1415823_at stearoyl-Coenzyme A desaturase 2 Scd2 1.39 0.001 1.29 0.15 1.23 0.45
1424119_at protein kinase beta 1 non-catalytic subunit Prkab1 1.44 0.000 1.28 0.15 1.11 0.80
1418438_at fatty acid binding protein 2, intestinal Fabp2 1.40 0.001 1.09 0.21 1.13 0.03
1416021_a_at fatty acid binding protein 5, epidermal Fabp5 1.63 0.000  1.19 0.17 1.14 0.57
1450779_at fatty acid binding protein 7, brain Fabp7 2.16 0.000 1.52 0.21 1.66 0.05
1425875_a_at leptin receptor Lepr 2.78 0.000  1.60 0.02  1.27 0.07
1420715_a_at peroxisome proliferator activated
receptor gamma
Pparg 1.99 0.000 1.53 0.01 1.11 0.73
1417900_a_at very low density lipoprotein receptor Vldlr 1.81 0.001 1.01 0.86  1.08 0.40
An extensive overview is listed in Table S2.
FC, fold change.
doi:10.1371/journal.pbio.0050002.t001
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m/m/Xpa
 /  Miceprocesses implicated in the derivation of energy from
oxidation of organic compounds, homeostasis of energy
reserves, cell growth and maintenance, and the redox status
of the cell.
Subsequent analysis of these processes led us to identify the
following four results.
(1) A profound attenuation of the somatotroph axis, as
evidenced by the consistent down-regulation of genes
encoding main components of the GH/IGF1 axis (e.g., IGF1,
Igfbp3, Igfbp4, Igfals, Ghr), as well as lactotroph (e.g., Prlr) and
thyrotroph functions (e.g., Dio1)i nCsb
m/m/Xpa
 /  livers, in
addition to a decrease in the expression of several genes
associated with a variety of mitogenic signals (e.g., Esr1, Fgf1,
Fgfr3, Fgfr4) (Table 1 and Table S2).
(2) An extensive suppression of catabolic metabolism in the
Csb
m/m/Xpa
 /  liver, as evident from the signiﬁcant down-
regulation of key genes involved in glycolysis, the tricarbox-
ylic acid cycle, and oxidative phosphorylation pathways
(Table 1 and Table S2), coupled with a signiﬁcant up-
regulation of genes associated with glycogen synthesis (e.g.,
Gyg1 and Gys2) and down-regulation of glycogen phosphor-
ylase (Pygl), suggesting that the Csb
m/m/Xpa
 /  liver stores
glucose into glycogen, rather than burn it for energy
derivation. These changes were further accompanied by the
broad down-regulation of genes associated with electron
transport and oxidative phosphorylation (e.g., several cyto-
chrome P450 monooxygenases, the NADH dehydrogenase
complex, and the NADPH-dependent oxidative metabolism)
(Table 1 and Table S2) and the signiﬁcant down-regulation of
several genes associated with peroxisomal biosynthesis (Table
1). Apparently, the complete catabolic metabolism is re-
strained in the Csb
m/m/Xpa
 /  liver.
(3) A broad up-regulation of genes associated with fatty
acid synthesis and transport (several genes listed in Table 1
and Table S2), the up-regulation of the receptor for the
adipocyte hormone leptin (Lepr), and the central fat regulator
peroxisome proliferator-activated receptor-gamma (Pparc).
Thus, similar to their reserved glucose utilization and
enhanced glycogen synthesis, Csb
m/m/Xpa
 /  mice attempt to
store rather than burn fat.
(4) An up-regulation of genes encoding key enzymatic and
nonenzymatic low–molecular mass scavengers and antioxi-
dant defense enzymes (e.g., Sod1, Prdx2 and 3, Txnip, Ephx1,
Hmox1 and ﬁve components of the glutathione system) (Table
1), suggesting that Csb
m/m/Xpa
 /  mice try to minimize the
induction of (DNA) damage by counteracting ROS.
None of these genes were identiﬁed as signiﬁcantly differ-
entially expressed in the livers of Csb
m/m or Xpa
 /  littermate
controls (Table 1). Quantitative real-time PCR (Q-PCR)
evaluation of the expression levels of key genes involved in
the somatotroph axis, energy metabolism, and antioxidant
defense in the livers of Csb
m/m/Xpa
 /  mice, and wt, Csb
m/m, and
Xpa
 /  littermates, as well as further biochemical analysis (see
below), conﬁrmed the validity of the microarray data (Figure
5A, upper left panel).
Postnatal Systemic Changes in Somatotroph Axis, Energy
Metabolism, and Antioxidant Defense in Csb
m/m/Xpa
 / 
Mice
Next we analyzed whether the onset of the aforementioned
transcriptional changes paralleled the progressive postnatal
growth attenuation as well as the weight loss observed later.
Consistent with the normal embryonic development, the
expression levels of genes involved in the somatotroph axis
(Ghr, Igf1, Prlr), antioxidant defense (Gstt2, Hmox1, Ephx1), and
oxidative metabolism (Gck, Gyg1, Cs, Ndufs8) did not differ
signiﬁcantly between wt and Csb
m/m/Xpa
 /  livers at postnatal
day 1 (Figure 5B). In contrast, during the ﬁrst 2 wk of life, wt
mice exhibited, as expected, a robust up-regulation in Igf1,
Ghr, and Prlr gene expression, a response that was virtually
absent in Csb
m/m/Xpa
 /  animals (Figure 5B, left panels); this
explains well the severe growth retardation of double-mutant
pups after birth. Analysis of Gstt2, Hmox1, and Ephx1 mRNA
levels revealed that the up-regulation of the antioxidant
defense system in the Csb
m/m/Xpa
 /  liver already initiated
before postnatal day 10, and thus occurs well ahead of the
initiation of the physiological decline (i.e., weight loss) (Figure
5B, middle panels). When comparing mRNA levels of key
genes in glycolysis (Gck), tricarboxylic acid cycle (Cs), and
mitochondrial oxidative phosphorylation (Ndufs8), we noticed
that beginning postnatal day 10, Csb
m/m/Xpa
 /  livers do not
show the prominent up-regulation of these catabolic genes
seen in the wt liver (instead, expression levels continued to
decline), whereas they up-regulate glycogen synthesis (Gyg1)
(Figure 2B, right panels). In agreement, the enzymatic activity
of citrate synthase was signiﬁcantly lower (p   0.01) in the
livers of 15-d-old Csb
m/m/Xpa
 /  mice (119 6 15 mU/mg
protein), as compared to wt littermate controls (70 6 13
mU/mg protein).
We next determined the expression levels of aforemen-
tioned genes in the kidney, heart, and spleen of the same set of
animals used in the microarray experiment. Expression levels
markedly mirrored the deviant expression patterns observed
in the liver, whereas mRNA levels in Csb
m/m and Xpa
 /  tissues
were not signiﬁcantly different from wt animals (Figure 5A).
Thus, attenuation of the GH/IGF1 axis and down-regulation of
metabolism, along with the enhanced antioxidant/detoxiﬁca-
tion response, represents a systemic rather than liver-speciﬁc
response of the Csb
m/m/Xpa
 /  pups to the DNA repair defect.
Interestingly, when 96-wk-old wt livers were tested for
expression levels of this same set of Csb
m/m/Xpa
 /  responsive
genes, we noticed a remarkable resemblance (Figure S1).
Comparison of the Csb
m/m/Xpa
 /  and Naturally Aged
Mouse Liver Transcriptomes
The previous result prompted us to investigate whether and
to which extent the gene expression changes in the Csb
m/m/
Xpa
 /  mouse liver overlap with those observed in a natural
aged liver. To this end, we ﬁrst compared the full mouse liver
transcriptome of adult 16-, 96- and 130-wk-old wt C57Bl/6J
mice (n¼4) with that of adult 8-wk-old wt C57Bl/6J mice (n¼4)
(Tables S3–S5). Using the same analytical method as applied to
the Csb
m/m/Xpa
 /  mouse livers, we identiﬁed homeostasis of
energy reserves, oxidative metabolism, along with cell growth
and maintenance to be signiﬁcantly overrepresented in 96-
and 130-wk-old wt mice, but not in 16-wk-old animals (Table
S6). These ﬁndings ﬁt well with previous studies, suggesting
the repression of oxidative metabolism to represent a
conserved response shared by highly diverged species [28].
Next we implemented a previously described method [29]
to evaluate the extent of genome-wide similarity between the
liver transcriptomes of 2-wk-old Csb
m/m/Xpa
 / mice and wt
animals of various ages. We ﬁrst classiﬁed all signiﬁcantly
differentially expressed genes in the Csb
m/m/Xpa
 /  liver tran-
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m/m/Xpa
 /  Micescriptome as having increased or decreased expression (as
compared to wt), and we asked how many of these genes
respond in a similar direction in the 16/8 wk, 96/8 wk, and 130/
8 wk datasets. If the Csb
m/m/Xpa
 / liver resembles an aged liver,
one expects the Spearman’s rank correlation coefﬁcient (r,
þ1.0 or  1.0 in case of perfect similarity or dissimilarity,
respectively, and 0.0 in case of no correlation) to increase with
age. Notably, whereas the liver transcriptome of Csb
m/m/Xpa
 / 
mutant mice was dissimilar to that of 16-wk-old wt mice
(Spearman’s r¼ 0.28), as it was with 15-d-old littermates, this
Figure 5. Expression Levels of Genes Associated with the Somatotroph Axis, Antioxidant Defense, and Metabolism in Mutant and wt Mouse Liver and
Other Organs at Various Ages
(A) Q-PCR evaluation of mRNA levels of genes associated with antioxidant defense (dark gray bars), oxidative metabolism (light gray bars), and the GH/
IGF1 axis (black bars) in the liver, kidney, heart, and spleen of 15-d-old Csb
m/m/Xpa
 / , Csb
m/m, and Xpa
 /  pups. For each gene, expression levels in the
mutant tissue are plotted relative to that of age-matched wt control tissues (dotted line). Error bars indicate SEM between replicates (n   3).
(B) Relative mRNA expression levels (fold changes, relative to embryonic day 18) of genes involved in the GH/IGF1 growth axis, antioxidant defense, and
oxidative metabolism in the liver of wt and Csb
m/m/Xpa
 /  pups, plotted as a function of time. Error bars indicate SEM between replicates (n   3).
doi:10.1371/journal.pbio.0050002.g005
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m/m/Xpa
 /  Miceturned into a positive correlation when the comparison was
made between the Csb
m/m/Xpa
 /  and 96-wk-old mouse liver
transcriptomes (r¼þ0.15) and even more with the 130-wk-old
wt mouse group (r ¼þ0.44, p   0.0001) (Figure 6A).
Comparable results were obtained when the same approach
was applied over the whole mouse transcriptome (including
all Affymetrix probe sets with signals above the detection
cutoff value; see Materials and Methods), thus avoiding any
initial preselection or introduction of bias. Using the same
approach, we did not ﬁnd a signiﬁcant correlation between
the liver transcriptomes of 15-d-old Csb
m/m or Xpa
 / mice and
aged wt mice.
The genome-wide resemblance between the short-lived
Csb
m/m/Xpa
 /  mice and the 130-wk-old mice was substantially
higher (.90%) when the comparison was restricted to those
functional categories that were signiﬁcantly overrepresented
in the double-mutant and 130-wk-old mice, such as the GH/
IGF1 axis, oxidative metabolism (i.e., glycolysis, Krebs and
oxidative phosphorylation), cytochrome P450 electron trans-
port, and peroxisomal biogenesis (Figure 6B and 6C and
Table S7). Despite the occurrence of dissimilarities between
the liver transcriptome of Csb
m/m/Xpa
 /  pups and aged wt
mice (the latter animals showing over-representation of genes
involved in the immune and inﬂammatory responses, ATP
biosynthesis, and protein glycosylation, along with a lack of
the anti-oxidant response), these ﬁndings strongly underline
the genome-wide parallels between the Csb
m/m/Xpa
 /  repair
mutants and natural ageing, thereby validating the progeria
in the double mutant pups.
Reduced IGF1 Serum Levels, Glucose, and Fat Use in
Csb
m/m/Xpa
 /  Mice
In agreement with the down-regulation of Igf1 gene
expression in the liver (the main source of circulating IGF1
[30]), we observed a signiﬁcant reduction (p , 0.004) in serum
IGF1 levels in Csb
m/m/Xpa
 /  mice (Figure 7A) together with
signiﬁcantly lower blood glucose levels (p , 0.04) (Figure 7B).
Following an initial reduction of ;30% (p , 0.04) in 7- and 10-
d-oldCsb
m/m/Xpa
 / mice,bloodglucoselevelsstartedtodropat
day 15, gradually reaching low levels in 17-d-old Csb
m/m/Xpa
 / 
Figure 6. Transcriptome Similarities between Csb
m/m/Xpa
 /  and Naturally Aged Mice
(A) Spearman’s r correlation of 16-, 96- and 130-wk-old mice with 15-d-old Csb
m/m/Xpa
 / mice, where 1.0 is a perfect negative (inverse) correlation, 0.0
is no correlation, and þ1.0 is a perfect positive correlation.
(B) Similarities between significantly overrepresented biological processes. Note that in both Csb
m/m/Xpa
 /  and naturally aged mice, transcriptional
changes were mostly associated with metabolic processes.
(C) Correlation in significant expression changes of genes associated with the GH/IGF1 axis and oxidative metabolism in the livers of Csb
m/m/Xpa
 / and
naturally aged (96- and 130-wk-old) mice. An extensive overview is listed in Tables S3 and S4.
doi:10.1371/journal.pbio.0050002.g006
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m/m/Xpa
 /  Micemice (;3 mM), contrasting the steady blood glucose levels (; 9
mM) in littermate controls (Figure 7B). The presence of milk
andfood in thestomach of the double-mutant pups along with
thenormalappearanceoftheintestinalepithelium(Figure3A)
indicates that the hypoglycemia is not due to food intake. Even
more,thesuppressionofthesomatotrophaxisandsubsequent
decreased IGF1 production in 15-d-old Csb
m/m/Xpa
 /  mice
appeared not to originate from a pituitary dysfunction as
histological examination (Figure 3F) and TUNEL staining of
sections from the pituitary pars distalis, intermedia, and
nervosa did not reveal any abnormalities (unpublished data).
Moreover,serum GH levelsin 15-d-old Csb
m/m/Xpa
 / mice (15.2
6 4.2 ng/ml, n ¼ 8) did not differ signiﬁcantly from wt
littermates (12.8 6 2.8 ng/ml, n¼6). Interestingly, the normal
serum GH levels together with the signiﬁcant systemic down
regulation of GH receptor gene expression likely point to
growth hormone resistance in 15-d-old Csb
m/m/Xpa
 /  mice.
Periodic acid-Schiff (PAS) staining of liver sections from
10- to 20-d-old pups and naturally aged mice revealed
enhanced accumulation of glycogen in unusually large
vesicles in Csb
m/m/Xpa
 /  pups and 96-wk-old mice when
compared to wt littermates and 8-wk-old wt mice (Figure
7C). This observation ﬁts our microarray data, suggesting that
both the Csb
m/m/Xpa
 /  and naturally aged mice store rather
than use glucose. Overnight fasting of Csb
m/m/Xpa
 /  pups and
littermate controls resulted in a near-to-complete depletion
of liver glycogen (Figure 7D), indicating that the glycogen
accumulation is not due to inability to split glycogen into its
constitutive glucose monomers.
Consistent with the broad up-regulation of genes associ-
ated with fatty acid synthesis (Table 1), Oil Red O staining of
liver sections from 15-d-old pups and naturally aged mice
revealed enhanced accumulation of triacylglycerides in both
compared to control littermates and 8-wk-old mice (Figure
7C), indicating hepatic steatosis. This and the absence of
adipose tissue suggest that Csb
m/m/Xpa
 /  mice display gener-
alized lipodystrophy (loss and abnormal redistribution of
body fat) [31].
Figure 7. Carbohydrate/Fat Metabolism and IGF1 Serum Levels
IGF1 (A) and glucose (B) in the serum of 7-, 10-, 15-, and 17-d-old wt, Xpa
 / , Csb
m/m, and Csb
m/m/Xpa
 /  mice (n ¼ 6). The levels of IGF1 (ng/ml) and
glucose (mmol/l) in the serum of Csb
m/m/Xpa
 / mice are significantly lower than that of control littermates (p , 0.0004 and p , 0.04, respectively). (C)
PAS staining for glycogen and Oil Red O staining for triglycerides in livers of 15-d-old wt and Csb
m/m/Xpa
 /  mice and 96-wk-old wt mice. Pictures were
taken at 1003magnification. Note the large polyploid nuclei in the 96-wk-old wt mouse liver and the reduced glycogen levels in the Csb
m/m/Xpa
 / liver
after overnight fasting.
doi:10.1371/journal.pbio.0050002.g007
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m/m/Xpa
 /  MiceSystemic Changes in Somatotroph Axis and Antioxidant
Defense in DEHP-Treated wt Mice
To test whether the presence of endogenous (oxidative)
DNA damage can provoke the somatotrophic drop and
enhanced antioxidant potential, wt C57BL/6J mice (n ¼ 6; 4-
wk-old) were fed ad libitum for 9 wk with standard food
containing subtoxic levels of an oxidative DNA damage-
inducing agent [di(2-ethylhexyl)phthalate (DEHP), 1500 ppm]
[32]. Neither body weight nor appetite and food intake of
DEHP-exposed animals deviated from that of untreated
control animals. As shown in Figure 8, subsequent analysis
revealed suppression of the expression of genes associated
with the somatotroph axis (Igf1, Igfbp3, Ghr, and Dio1) and
oxidative metabolism (Gck, Cs, and Ndufs8), along with the up-
regulation of glycogenin 1 (Gyg1, Figure 5A) in DEHP-
exposed animals. Consistent with the ability of DEHP to
generate ROS-induced DNA damage in the liver, we also
noticed a signiﬁcant up-regulation of genes associated with
the antioxidant and detoxiﬁcation responses (Hmox1, Ephx1,
Gsr, Sod1, Gstt2). These ﬁndings suggest that the accumulation
of unrepaired (oxidative) DNA damage is likely one of the
causes underlying the observed suppression of the GH/IGF1
and oxidative metabolism in Csb
m/m/Xpa
 /  mice (Text S1).
Discussion
Csb
m/m mice exhibit several CS features (e.g., attenuated
growth, blindness, neurological dysfunction), but their
phenotype is overall milder than the human syndrome [16]
despite the fact that the truncation in the N-terminal part
(mimicking a mutant allele of CS-B patient CS1AN) com-
pletely inactivates the protein and TC-NER [16]. Although the
severity of clinical features in humans does not seem to
correlate with the severity of the molecular defect [33], the
absence of the complete spectrum of CS features in the Csb
m/m
mouse model is likely to originate from human-mouse
differences (i.e., adaptation to stress, tolerance to DNA
damage/genome instability), rather than from the nature of
the Csb
m/m mutation. This idea is supported by our observa-
tions that Xpd
TTD and Xpd
XPCS mice (all carrying causative
point mutations) also fail to show the severe CS features
associated with XPCS and TTD [9,34].
Yet, the present study reveals that inactivation of GG-NER
or complete abrogation of NER (through inactivation of Xpc
or Xpa, respectively) in TCR-deﬁcient Csb
m/m mice dramati-
cally aggravates the Csb
m/m mouse phenotype. Because animals
were not exposed to exogenous genotoxic agents, we
attribute this effect to enhanced levels of unrepaired
endogenous (oxidative) DNA damage. In further support of
this, we have shown that Csb
m/m/Xpc
 /  and Csb
m/m/Xpa
 /  MEFs,
as well as Csb
m/m/Xpa
 /  retinal photoreceptor cells, are more
sensitive to environmental genotoxic insults (i.e., UV light
and ionizing radiation) than their single mutant counter-
parts. A comparable phenotypic deterioration has been
noticed when Xpa was inactivated in Xpd
TTD [9], Xpd
XPCS
[34], compound heterozygous Xpd
TTD/XPCS animals (carrying
causative mutations for TTD and combined XP/CS) [35] or
Xpg
deltaEx15 mice [36].
Importantly, Csb
m/m/Xpa
 /  mice appeared normal at birth,
indicating a normal intra-uterine development and ruling out
that this condition is in fact an embryonic developmental
disorder. Instead, after birth, the Csb
m/m/Xpa
 /  pups displayed
progressive kyphosis, cachexia, photoreceptor loss, and motor
dysfunction, all common postnatal manifestations of CS [13],
as well as of natural mammalian ageing [37–39]. Also similar to
human CS patients (average age 12.5 y), Csb
m/m/Xpa
 / pups fail
to grow into adulthood and die before weaning. The relation
between (residual) repair capacity, time, and severity of a
particular phenotype is well illustrated by the retinal photo-
receptor loss in the Csb
m/m mouse models. Whereas ageing
C57Bl/6J mice lose about 5%–10% of their rods and cones in
30 months, TCR-deﬁcient Csb
m/m mice have already lost about
50% of their photoreceptor cells by the age of 16 months. This
spontaneous retinal degeneration in Csb
m/m mice originates
from enhanced apoptotic sensitivity of photoreceptor cells (T.
Gorgels, I. van der Pluijm, R. Brandt, G. Garinis, H. van Steeg,
et al, unpublished data), evolving in the ﬁrst 1 or 2 months
afterweaning. Interestingly, further crippling of NER in Csb
m/m
animals by inactivation of Xpa accelerates the onset of
photoreceptor loss, which becomes visible as early as postnatal
day 15, and progressively increases thereafter. The strong
correlation between the severity of the repair deﬁciency and
the onset of photoreceptor loss, as well as the enhanced
ionizing radiation hypersensitivity of photoreceptor cells of
Csb
m/m/Xpa
 /  mice (as compared to age-matched Csb
m/m
animals), well support the hypothesis that (oxidative) DNA
damage likely underlies the retinal degeneration.
Full genome transcriptome analysis of the Csb
m/m/Xpa
 / 
mouse liver, aiming at unraveling the etiology of the severe
double-mutant phenotype, led us to identify signiﬁcant
genome-wide parallels between the 2-wk-old Csb
m/m/Xpa
 / 
and 130-wk, but not 16-wk-old, wt animals at the fundamental
level of gene expression. This resemblance was largely
attributable to the substantial down-regulation of genes
associated with processes implicated in oxidative energy
and growth metabolism that were previously revealed by
others to represent a conserved transcriptional response in
ageing [28].
Figure 8. Expression Levels of Genes Associated with the GH/IGF1 Axis,
Oxidative Metabolism, and Antioxidant Defense in DEHP-Treated wt Mice
Relative mRNA levels of genes involved in the GH/IGF1 growth axis,
oxidative metabolism, and antioxidant defense in 13-wk-old wt mice
treated with a low dose of the pro-oxidant DEHP. For each gene,
expression levels in the treated wt mouse livers are plotted relative to
that of age-matched untreated wt littermate controls (dotted line). Error
bars indicate SEM. Asterisks indicate statistically significant differences
(one-tailed p   0.05, see also Text S1).
doi:10.1371/journal.pbio.0050002.g008
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m/m/Xpa
 /  MiceThe down-regulation of genes associated with the GH/IGF1
growth axis in the liver, the systemic reduction in GH receptor
mRNA levels, and the impaired Igf1 gene expression in liver
and other tissues (resulting in low serum IGF1 levels) likely
underlie the postnatal growth defect in Csb
m/m/Xpa
 /  pups.
These changes were not due to reduced GH serum levels or
pituitary abnormalities. A steady decline in the GH/IGF1
somatotroph axis was also observed in rodents and humans
during natural ageing [40]. Furthermore, Csb
m/m/Xpa
 /  pups
failed to up-regulate metabolism; instead, they displayed a
sharp systemic reduction in the expression levels of genes
involved in glycolysis, tricarboxylic acid cycle (including
decreased citrate synthase activity), and oxidative respiration,
which coincided with the onset of weight loss (cachexia). In
addition, Csb
m/m/Xpa
 /  pups up-regulated genes associated
with glycogen and fatty acid synthesis, leading to increased
hepatic glycogen storage and fat accumulation (steatosis) and
pronounced hypoglycemia. Simultaneously, subcutaneous fat
tissue was virtually absent. Given that in mammals, the GH/
IGF1 signaling pathway is one of the major regulators of
energy homeostasis to integrate metabolism with growth
[30,41,42], it is tempting to speculate that reduced IGF1
signaling is responsible for the postnatal metabolic shift and
growth defect seen in Csb
m/m/Xpa
 / mice. Interestingly, several
CS patients have been previously reported with hypoglycemia
and low IGF1 serum levels [43,44], low metabolic rate [45],
and abnormal fat deposition [46].
Paradoxically, however, the systemic suppression of the
somatotrophic axis and energy metabolism, along with the
up-regulation of antioxidant defenses, low IGF1 serum levels,
and low blood glucose levels observed in the Csb
m/m/Xpa
 / 
mouse, are all associated with increased longevity rather than
with the short lifespan of this mouse model. In lower
paradigms for lifespan extension (C. elegans, D. melanogaster),
genetic interference in the insulin-signaling pathway can
prolong life multi-fold [47,48]. In mammals, IGF1-deﬁcient,
Ames and Snell dwarf mice (characterized by defects in the
development of the anterior pituitary due to mutations in the
Prop-1 and Pit1 loci and diminished levels of GH, thyroid
stimulating hormone, and prolactin hormone) combine
hypoglycemia, low body temperature, and increased storage
of carbohydrates and lipids [40,42] with up-regulation of
antioxidant defense capacity and extended lifespan [49,50].
Conversely, GH-overexpressing transgenic mice display re-
duced lifespan and antioxidant responses [51]. These ﬁndings
have also been recently conﬁrmed by our identiﬁcation of
genome-wide parallels between the extremely short-lived
DNA repair mutants (Csb
m/m/Xpa
 /  and Ercc1
 / ) and the
extremely long-lived Ames and Snell dwarfs and growth
hormone receptor knockout (Ghr
 / ) mice (Garinis et al.
manuscript in preparation). Last but not least, IGF1 plasma
levels decline with age in humans and rodents [52–54]. Along
with this hormonal shift, ageing cells surmount an intricate
antioxidant defense response [55,56] that is thought to
prevent the detrimental consequences of oxidative stress.
Interestingly, the progressive, age-related decrease in the
somatotroph axis has been suggested to confer a selective
advantage by postponing the onset of age-related disease and
prolonging lifespan through the reduction of toxic free
radicals [40].
How would repair-deﬁcient mice beneﬁt from such a
response? During development, the mitogenic action of GH
and IGF1 fuels cellular metabolism, thereby promoting tissue
growth and function [40,57,58]. A high metabolic activity,
however, leads to higher oxygen consumption [40] and may
also increase the ROS burden through the parallel increase of
mitochondrial electron transport, peroxisomal fatty acid
metabolism, and/or microsomal cytochrome P-450 enzymes
[59]. Despite antioxidant defense and DNA repair, oxidative
DNA damage will still accumulate, leading to transcriptional
stress, impaired replication, cellular senescence, malfunction
or death and eventually to progressive loss of tissue homeo-
stasis and organismal decline (Figure 9, model). We hypothe-
size that complete abrogation of NER (by inactivation of Xpa)
renders TCR-deﬁcient Csb
m/m mice unable to adequately cope
with the increased burden of DNA damage in the transcribed
strand of active genes. This triggers an adaptive response; i.e.,
reduction of metabolic activity through down-regulation of
the GH/IGF1 axis to relieve the pressure on their genome. We
interpret this as an attempt to limit the deleterious effects of
arrested transcription, such as cellular senescence and death
causing accelerated ageing. As a consequence, the initially
normal growth becomes arrested soon after birth, leading to
severe growth retardation. This scenario provides a plausible
explanation for the growth defect in CS patients. However,
this response is unable to fully compensate for the repair
defect, and thus damage still accumulates to critical levels and
Figure 9. The Proposed Link between DNA Damage and the Decline of
the GH/IGF1 Somatotroph Axis
ROS are natural byproducts of metabolism and can injure several
macromolecules including DNA, thus contributing to a slow but steady
accumulation of damage, transcriptional stress, impaired replication, and
eventually the progressive loss of tissue homeostasis and gradual
organismal deterioration. Cells and tissues will respond by (1) up-
regulating their antioxidant defense responses that would moderate the
harmful effects of ROS, (2) using a battery of genome maintenance
pathways that would repair or remove damaged macromolecules and
help to resist the oxidative stress, and (3) suppressing their GH/IGF1
somatotroph axis along with the oxidative metabolism, thus substan-
tially moderating their metabolic activity that would otherwise lead to
high oxygen consumption and increased generation of oxidants. To this
end, the physiologic reduction of the somatotroph axis and oxidative
metabolism is envisaged to be beneficial in terms of net lifespan.
doi:10.1371/journal.pbio.0050002.g009
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m/m/Xpa
 /  Micetriggers apoptosis and/or senescence, thereby leading to
ageing-associated pathology such as neurodegeneration (as
illustrated by the photoreceptor cells in Csb
m/m/Xpa
 /  mice).
The conceptual link between DNA damage and the
systemic adaptive response is supported by our observation
that chronic exposure of wt mice to a sub-toxic dose of
DEHP (a pro-oxidant that enhances the DNA damage load;
[60]) triggers a response similar to that observed in
(untreated) Csb
m/m/Xpa
 /  mice. Although DEHP at much
higher concentrations has been previously documented to
affect the endocrine function of the pituitary, proteome
analysis revealed that synthesis of prolactin and growth
hormone appears unaffected in DEHP-treated rats [61]. This
suggests that the observed suppression of genes associated
with the somatotroph axis and oxidative metabolism in the
liver of DEHP-exposed mice is triggered by DNA damage in
the liver, rather than by a pituitary defect or hypothalamic
defect.
As one would predict, other short-lived NER mouse models
(e.g., Xpg and Xpf mice [62,63]) or NER mutant mice with a
milder progeroid phenotype could also show accelerated
attenuation of the somatotrophic axis in response to their
DNA repair defect. Indeed, Ercc1
 /  animals, carrying a
combined NER/crosslink DNA repair defect and a lifespan
of only a few weeks, demonstrate a remarkable genome-wide
similarity in liver gene expression proﬁles with Csb
m/m/Xpa
 / 
mice (L. Niedernhofer, G. Garinis, A. Raams, A. Lalai, A. Rasile
Robinson, et al., unpublished data), whereas Xpd
XPCS/Xpa
 / 
and compound heterozygous Xpd
TTD/XPCS/Xpa
 /  mice contain
lower serum IGF1 levels [35]. Furthermore, Xpd
TTD mice,
which manifest accelerated ageing in many (but not all) organs
and tissues, have recently been shown to display features
related to a caloric restricted–like phenotype and suppression
of the GH/IGF1 axis in a limited set of organs and tissues,
stressing the segmental nature that is characteristic of all
progeroid syndromes and the systemic nature of the response
[64]. Finally, proper glucose homeostasis and normal IGF1
levels were recently shown to require activity of Sirt6, a
chromatin deacetylase that may promote DNA repair [65].
Because ROS-mediated DNA damage appears to be the
underlying cause of the Csb
m/m/Xpa
 /  progeria, it is tempting
to speculate that one can attenuate the premature onset of
age-related features by directly counteracting the harmful
byproducts of metabolism (ROS) and, consequently, DNA
damage. An antioxidant-based nutraceutical intervention
pilot study with Csb
m/m/Xpa
 /  mice, aiming at extending
lifespan and delaying onset of pathology, yielded promising
results (I. van der Pluijm, R. Brandt, J. Hoeijmakers, G. van der
Horst, unpublished data).
Materials and Methods
Animals. The generation and characterization of NER-deﬁcient
Xpa
 / ,X p c
 / , and Csb
m/m mice has been previously described
[16,22,66,67]. p53
 /  mice [68] were kindly provided by T. Jacks
(Massachusetts Institute of Technology, Cambridge, Massachusetts,
United States). Unless stated otherwise, all mice were kept in a
C57BL/6J genetic background. In the DEHP exposure study, 4-wk-old
male wt mice (C57BL/6J; n ¼ 6) were put on a DEHP (1500 ppm;
Sigma, St. Louis, Missouri, United States) containing diet or on a
regular diet for 9 wk. Animals were screened daily for discomfort and
weighed once a week. Food consumption was registered by weighing
the food. In the ionizing irradiation exposure study, 18-d-old Csb
m/m/
Xpa
 /  and littermate control animals (n ¼ 4–6/genotype) were
exposed to 10 Gy, killed 20 h after exposure, and their eyes were
further processed. Additional information on the isolation and
processing of the eyes is provided in the Text S1. As required by
Dutch law, all animal studies were approved by an independent
Animal Ethical Committee (Dutch equivalent of the Institutional
Animal Care and Use Committee). Further information on mouse
crossing, genotyping, housing, and macroscopic examination is
described in the Text S1.
Cellular sensitivity studies. UV sensitivity was determined as
described [69]. Sparsely seeded Petri dish cultures were exposed to
different doses of UV (254 nm, Phillips TUV lamp). After 4 d, the
number of proliferating cells was estimated from the amount of
radioactivity incorporated during a 2-hr pulse with [
3H] thymidine.
Cell survival was expressed as the percentage of radioactivity in
exposed cells in relation to the radioactivity in untreated cells. UV-
induced GG repair was assayed using the unscheduled DNA synthesis
(UDS) method described in [70]. In brief, coverslip-grown cells were
exposed to 16 J/m
2 of 254-nm UV light and labeled with [
3H]
thymidine. Repair capacity was quantiﬁed by grain counting after
autoradiography. RNA synthesis recovery was measured according to
[71]. In short, coverslip-grown cells were exposed to 10 J/m
2 of 254-nm
UV light, allowed to recover for 16 hr, labeled with [
3H] uridine, and
processed for autoradiography. The relative rate of RNA synthesis was
expressed as GUV/GC (percentage), where GUV and GC represent the
number of grains over UV-exposed and nonexposed nuclei, respec-
tively.
Ionizing radiation sensitivity of immortalized MEFs was deter-
mined using a colony assay. Cells were plated in 6-cm-diameter dishes
at various densities. After 16 h, cells were exposed to a single dose of
ionizing radiation (
137Cs source; dose range of 0 to 8 Gy. Cells were
grown for another 5 to 14 d, and after ﬁxation and staining, colonies
were counted. All experiments were performed in triplicate.
Immunohistological examination and blood parameters. Detailed
histopathological examination was performed on all organs and
tissues. Parafﬁn-embedded tissues were sectioned at 5 lm and stained
with haematoxylin/eosin (HE) solution. Liver sections were stained
with PAS or Oil Red O (cryosections) to detect glycogen and
triglycerides, respectively. Detailed information on the immunohis-
tochemical procedures is described in Text S1. Apoptotic cells were
detected using a TUNEL assay as described by the manufacturer
(Apoptag Plus Peroxidase In Situ Apoptosis Detection Kit, Chem-
icon, Temecula, California, United States). For retinal evaluation,
eyes were marked nasally with Alcian blue (5% Alcian blue in 96%
ethanol), enucleated, ﬁxed in 4 % paraformaldehyde in 0.1 M
phosphate buffer, washed in PBS, and embedded in parafﬁn.
Horizontal sections (5 lm thick) of the retina were cut, and sections
in the middle of the retina were selected by Alcian blue marking and
proximity of the optic nerve. Sections were stained for degenerating
cells by TUNEL according to the manufacturer’s instructions
(Apoptag Plus Peroxidase In Situ Apoptosis Detection Kit, Chem-
icon). For quantiﬁcation, the number of TUNEL-positive cells in the
INL and ONL were counted in six whole sections per mouse.
Differences between the genotypes were tested for statistical
signiﬁcance using multivariate ANOVA, followed by a posthoc test
of Student-Newman-Keuls (S-N-K). Signiﬁcance was set at p , 0.05.
Serum IGF1 and GH levels were determined with the active mouse/
rat IGF1 enzyme-linked immunosorbent assay (ELISA) and active
mouse/rat GH ELISA kits respectively, as described by the manu-
facturer (Diagnostic Systems Laboratories Inc., Texas, United States).
Blood glucose was measured using a Freestyle mini blood glucose
measurement device (Abbott Diabetes Care, Amersfoort, The
Netherlands).
Radiography and microcomputed tomography. Mice were anaes-
thetized by intraperitoneal injection of ketalin and rompun (120 and
7.5 lg/g body weight, respectively). Lateral ﬁlms were taken at 23
magniﬁcation using a CGR Senograph 500T x-ray system operated at
30 kV and 32 mAS [9]. Formalin ﬁxed tibiae from wt and mutant mice
were scanned from proximal end to mid-diaphysis, using a SkyScan
1072 microtomograph (SkyScan, Antwerp, Belgium) with a voxel size
of 8.82 lm. Scans were processed, and 2-D images of the bones were
obtained.
Footprint studies. Footprintanalysiswasperformedbypaintingthe
hind and fore paws of the mice with different colors of water-soluble
nontoxicpaints.Animalswereallowedtowalkalonga3037cmwalled
runway, lined with paper, into a darkened, enclosed space. Tests were
performed in duplicate at day 15 and 19. Footprint patterns were
analyzed for (1) stride length, measured as the average distance
between each stride; (2) front base width; and (3) hind base width,
measuredastheaveragedistancebetweencontralateralfootprints[72].
Microarray analysis and Q-PCR evaluation. Standard procedures
were used to obtain total RNA (Qiagen, Valencia, California, United
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m/m/Xpa
 /  MiceStates)from the liver of wt, Xpa
 / , Csb
m/m, and Csb
m/m/Xpa
 / mice (n¼4)
at postnatal day 15 and from the liver of 8-, 16-, 96-, and 130-wk-old
mice (n ¼ 4). Synthesis of double stranded cDNA and biotin-labeled
cRNA was performed according to the instructions of the manufac-
turer (Affymetrix, Santa Clara, California, United States). Fragmented
cRNA preparations were hybridized to full mouse genome oligonu-
cleotide arrays (430 V2.0; Affymetrix). Q-PCR was performed with a
DNA Engine Opticon device (Bio-Rad Laboratories B.V., Veenendaal,
The Netherlands). Detailed information on microarray hybridization,
microarray data analysis, gene ontology classiﬁcation, and analysis of
overrepresented biological themes, as well as on Q-PCR data analysis
and used primer pair sequences is described in Text S1. Microarrays
were complied with the Minimum Information for Microarray
Experiments (MIAME, E-MEXP-835 and E-MEXP-839).
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